Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : T/FIF Portfolio -- Ignore unavailable to you. Want to Upgrade?

To: Mike McFarland who wrote (911)	5/28/1999 1:12:00 AM
From: Mike McFarland	Read Replies (1) \| Respond to of 1073

(continued) which is to say, If SUGN gets above $20 tomorrow (and it will, oh it'll gap up a buck easy), then I'd swap it for CELG. Moving over to the biotech/Health funds, looks like JAGLX is only up a few percent for the year, owning MNWBX hasn't done anything for you, HQL is fairly stuck on $12, and HQH is is down a bit for the year. FBIDX has not made anybody money this year, and FBIOX started the year close to $40, and that's about where it is now. So, correct me if I am wrong, but there still is no compelling reason to buy these fella's funds is there? I mean, my strategy is simply to bottomfish what in the past has been considered to be biotechs with good science, and disregard the punishment they've endured up til now-- the do or die high risk high reward theory. It has me up 20% with no effort so far...but I could cut and run over to INCY and SEPR right now too--if I thought I was wrong to be in nano caps: So somebody tell me I am wrong to be playing my high stakes poker with the really cheap stuff.